셀룰라이트 치료 시장 - 산업 규모, 점유율, 동향, 기회, 예측 : 절차 유형별, 셀룰라이트 유형별, 최종 용도별, 지역별 경쟁(2021-2031년)

The Global Cellulite Treatment Market is projected to expand significantly, growing from USD 1.61 Billion in 2025 to USD 2.54 Billion by 2031, exhibiting a robust 7.89% CAGR. This market encompasses both non-invasive and minimally invasive aesthetic procedures aimed at reducing the dimpled appearance of skin caused by subcutaneous fat deposits, predominantly on the thighs and buttocks. Key drivers fueling this growth include the increasing global prevalence of obesity and an aging population, both of which contribute to skin laxity and cellulite formation. Additionally, heightened consumer awareness regarding body contouring, coupled with a preference for clinical interventions that require minimal recovery time, actively supports industry demand, with 331,981 cellulite treatment procedures performed globally in 2023, according to the International Society of Aesthetic Plastic Surgery (ISAPS).

However, significant challenges hinder broader market expansion, notably the high cost of these elective procedures and the complete absence of medical reimbursement. Since cellulite reduction is classified as a cosmetic intervention, patients are fully responsible for the expenses, limiting market penetration among price-sensitive consumers. Furthermore, the frequent need for multiple treatment sessions to achieve and maintain visible results can deter potential clients, thereby constraining the overall customer base.

Market Driver

The primary catalyst for the expansion of the Global Cellulite Treatment Market is the surging consumer demand for non-invasive and minimally invasive procedures, as patients increasingly favor aesthetic interventions that deliver effective results with reduced recovery times and lower risks compared to traditional surgical options. This trend is particularly evident in cellulite reduction, where energy-based devices and injectables are gaining preference over invasive surgery, significantly boosting the volume of treatments performed; the American Society of Plastic Surgeons reported over 28.5 million minimally invasive cosmetic procedures in 2024.

Additionally, increasing global disposable income and heightened spending on aesthetic care play a crucial role in propelling market growth, as improved economic conditions empower consumers to invest in elective cosmetic treatments to enhance body image and self-confidence. This financial capacity expands access to premium aesthetic services, including advanced cellulite reduction therapies, with Galderma reporting record net sales of $4.4 billion for the full year 2024, reflecting sustained financial momentum. The market also benefits from the continued relevance of surgical interventions, with 17.4 million surgical procedures performed worldwide in 2024, as noted by the International Society of Aesthetic Plastic Surgery.

Market Challenge

The most significant impediment to the growth of the Global Cellulite Treatment Market is the high cost of these elective procedures, exacerbated by the complete absence of medical reimbursement. As cellulite reduction is strictly categorized as a cosmetic enhancement rather than a medical necessity, insurance providers offer no coverage, compelling patients to bear the entire financial burden out-of-pocket. This substantial financial barrier effectively excludes a large demographic of price-sensitive consumers who might otherwise seek treatment. The economic strain is further compounded by the clinical requirement for multiple sessions to achieve perceptible results, which significantly escalates the patient's total investment.

Consequently, this high cost-of-entry directly stifles procedure volumes and market expansion, as potential clients are often deterred by the recurring expenses necessary to maintain outcomes, leading to lower patient retention and acquisition rates. This trend of reduced engagement in body-focused interventions is underscored by recent industry data from the International Society of Aesthetic Plastic Surgery (ISAPS), which reported a 14.8% decrease in the total number of body and extremities procedures performed globally in 2024 compared to the previous year, highlighting a distinct shift in consumer spending away from these high-cost body treatments.

Market Trends

The market is currently undergoing a decisive shift toward acoustic wave and radiofrequency technologies, driven by their proven ability to effectively target subcutaneous fat and stimulate collagen production. These energy-based devices consistently deliver favorable outcomes, fostering a business model that increasingly relies on recurring consumable usage rather than solely on initial capital equipment sales. This technological evolution enables practitioners to treat cellulite at various depths, significantly improving patient retention, with Sofwave Medical reporting a 79% year-over-year growth in pulse recurring revenue, reaching $23.3 million in 2024, which underscores the successful integration of these platforms into clinical practices.

Simultaneously, there is a growing clinical emphasis on synergistic combination therapies, which involve pairing energy-based treatments with injectables or mechanical subcision to comprehensively address the multifactorial nature of cellulite. This strategic shift moves beyond single-modality approaches, allowing providers to customize protocols that simultaneously target fibrous septae and skin laxity for enhanced and more durable results. By integrating diverse mechanisms, clinics are now able to offer comprehensive body contouring solutions, a strategy proven commercially viable as evidenced by Sisram Medical's total annual revenue of $349.1 million in 2024, driven by an ecosystem combining devices and injectables to meet varied consumer needs.

Key Market Players

• Hologic, Inc.
• Merz Pharma GmbH & Co. KGaA
• Syneron Medical Ltd
• Zimmer MedizinSysteme GmbH
• Alma Lasers Ltd
• Cymedics Holding S.R.O.
• Beijing Nubway S&T Co., Ltd.
• Candela Corporation
• Cutera Inc.
• Tanceuticals LLC

Report Scope

In this report, the Global Cellulite Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cellulite Treatment Market, By Procedure Type

• Non-invasive treatment
• Minimally invasive treatment
• Topical treatment

Cellulite Treatment Market, By Cellulite Type

• Soft cellulite
• Hard cellulite
• Edematous cellulite

Cellulite Treatment Market, By End-use

• Hospitals
• Clinics & beauty Centers
• Others

Cellulite Treatment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cellulite Treatment Market.

Available Customizations:

Global Cellulite Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cellulite Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure Type (Non-invasive treatment, Minimally invasive treatment, Topical treatment)
  • 5.2.2. By Cellulite Type (Soft cellulite, Hard cellulite, Edematous cellulite)
  • 5.2.3. By End-use (Hospitals, Clinics & beauty Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Cellulite Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure Type
  • 6.2.2. By Cellulite Type
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cellulite Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure Type
      • 6.3.1.2.2. By Cellulite Type
      • 6.3.1.2.3. By End-use
  • 6.3.2. Canada Cellulite Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure Type
      • 6.3.2.2.2. By Cellulite Type
      • 6.3.2.2.3. By End-use
  • 6.3.3. Mexico Cellulite Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure Type
      • 6.3.3.2.2. By Cellulite Type
      • 6.3.3.2.3. By End-use

7. Europe Cellulite Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure Type
  • 7.2.2. By Cellulite Type
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cellulite Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure Type
      • 7.3.1.2.2. By Cellulite Type
      • 7.3.1.2.3. By End-use
  • 7.3.2. France Cellulite Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure Type
      • 7.3.2.2.2. By Cellulite Type
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Cellulite Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure Type
      • 7.3.3.2.2. By Cellulite Type
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Cellulite Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure Type
      • 7.3.4.2.2. By Cellulite Type
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Cellulite Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure Type
      • 7.3.5.2.2. By Cellulite Type
      • 7.3.5.2.3. By End-use

8. Asia Pacific Cellulite Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure Type
  • 8.2.2. By Cellulite Type
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cellulite Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure Type
      • 8.3.1.2.2. By Cellulite Type
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Cellulite Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure Type
      • 8.3.2.2.2. By Cellulite Type
      • 8.3.2.2.3. By End-use
  • 8.3.3. Japan Cellulite Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure Type
      • 8.3.3.2.2. By Cellulite Type
      • 8.3.3.2.3. By End-use
  • 8.3.4. South Korea Cellulite Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure Type
      • 8.3.4.2.2. By Cellulite Type
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Cellulite Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure Type
      • 8.3.5.2.2. By Cellulite Type
      • 8.3.5.2.3. By End-use

9. Middle East & Africa Cellulite Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure Type
  • 9.2.2. By Cellulite Type
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cellulite Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure Type
      • 9.3.1.2.2. By Cellulite Type
      • 9.3.1.2.3. By End-use
  • 9.3.2. UAE Cellulite Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure Type
      • 9.3.2.2.2. By Cellulite Type
      • 9.3.2.2.3. By End-use
  • 9.3.3. South Africa Cellulite Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure Type
      • 9.3.3.2.2. By Cellulite Type
      • 9.3.3.2.3. By End-use

10. South America Cellulite Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure Type
  • 10.2.2. By Cellulite Type
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cellulite Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure Type
      • 10.3.1.2.2. By Cellulite Type
      • 10.3.1.2.3. By End-use
  • 10.3.2. Colombia Cellulite Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure Type
      • 10.3.2.2.2. By Cellulite Type
      • 10.3.2.2.3. By End-use
  • 10.3.3. Argentina Cellulite Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure Type
      • 10.3.3.2.2. By Cellulite Type
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cellulite Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Hologic, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merz Pharma GmbH & Co. KGaA
• 15.3. Syneron Medical Ltd
• 15.4. Zimmer MedizinSysteme GmbH
• 15.5. Alma Lasers Ltd
• 15.6. Cymedics Holding S.R.O.
• 15.7. Beijing Nubway S&T Co., Ltd.
• 15.8. Candela Corporation
• 15.9. Cutera Inc.
• 15.10. Tanceuticals LLC

16. Strategic Recommendations

17. About Us & Disclaimer